Picture of Morphosys AG logo

MOR Morphosys AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Deals of the day-Mergers and acquisitions

April 29 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 0930 GMT on Monday:

    ** Morphosys  MORG.DE  said its takeover by Novartis
 NOVN.S  was still expected to be closed in the first half of
this year, in a statement responding to a possible safety risk
reported by specialist news website STAT News that knocked the
company's share price.
     urn:newsml:reuters.com:*:nS8N3EN05K
    
    ** An adviser to BHP  BHP.AX  on its $39 billion Anglo
American  AAL.L  bid is seeking views from some of its
shareholders as the miner weighs making a revised offer after
its initial proposal was rejected last week, sources said.
     urn:newsml:reuters.com:*:nL1N3H20HV
    
    ** French IT firm Atos  ATOS.PA  put a price tag on a state
offer to take over strategic parts of the company , boosting its
shares, but also said it would need almost twice as much cash as
estimated earlier this month to stay afloat.
     urn:newsml:reuters.com:*:nL8N3H216O
    
    ** Blackstone  BX.N  has agreed to acquire Hipgnosis Songs
Fund  SONG.L  for about $1.57 billion, trumping an offer from
Concord for the music rights owner of artists such as Shakira
and Red Hot Chili Peppers, the companies said.
     urn:newsml:reuters.com:*:nL4N3H2174
    
    ** Australia's Pacific Smiles Group  PSQ.AX  said  it
recommended a takeover offer from National Dental Care (NDC)
HoldCo, valuing the dental centres operator at A$303 million
($198.07 million).
     urn:newsml:reuters.com:*:nL4N3H10P9
    
    ** The billionaire owner of L'Occitane International
 0973.HK  is close to making a proposal to take the French
skincare firm private as early as Monday in a deal that could
value it at about $7 billion including debt, Bloomberg News
reported.
     urn:newsml:reuters.com:*:nL1N3H10FD

 (Compiled by Rajarshi Roy in Bengaluru)
 ((Rajarshi.Roy@thomsonreuters.com;))

Recent news on Morphosys AG

See all news